Pfizer Inc.’s vaccine has been less effective at keeping people from getting the coronavirus in Israel in recent weeks, but it continues to provide a strong shield against severe COVID-19, according to government data.
The vaccine protected 64% of people against the illness between June 6 and early July, down from a previous 94%. The drop was observed as the delta variant was spreading in Israel, the Health Ministry said. It also coincided with the lifting of virus restrictions at the start of June.
Despite the indications of increased infections, the data also showed the shot is protecting people from severe illness. Its effectiveness at preventing hospitalization fell to 93%, according to the Health Ministry, compared with at least 97% in an earlier government study.
Delta, which first emerged in India, is spreading around the globe as governments race to inoculate people. The mutation has forced some countries to delay or rethink plans to loosen curbs on businesses, activity and travel.
Pfizer spokeswoman Dervila Keane declined to comment on the data from Israel. She pointed to research showing the vaccine’s continued protection against new mutations — just slightly reduced in some cases. The evidence so far suggests that the vaccine “will continue to protect against these variants,” she said.
KEYWORDS
In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.

With your current subscription plan you can comment on stories. However, before writing your first comment, please create a display name in the Profile section of your subscriber account page.